Learn more about whether Penumbra, Inc. or TransMedics Group, Inc. is a better investment based on AAII's A+ Investor grades, ...

Learn more about whether Penumbra, Inc. or PROCEPT BioRobotics Corporation is a better investment based on AAII's A+ Investor ...

Analyst Price Forecast Suggests 20.98% Upside As of March 4, 2025, the average one-year price target for Penumbra is $315.31/share. The forecasts range from a low of $262.60 to a high of $357.00.

Bank of America launched its coverage of medical device maker Penumbra (NYSE:PEN) with a Buy recommendation on Friday, citing a broader commercial rollout of the company’s latest clot-removal ...

Penumbra's shares have surged again on renewed confidence in mechanical thrombectomy growth and a competitor's acquisition, but the current valuation is high at over 7x 2025 revenue estimate ...

The second shadow in an eclipse is known as the penumbra (pronounced peh NUM bruh). This partial outer shadow is lighter than the umbra and gets larger as it goes away from the sun. Lunar ...

At the Scotiabank Dance Centre on Thursday, March 2. Continues until March 4 The star of In Penumbra is its spangly light-bulb canopy, a scalloped silver mesh covered in an array of glowing glass.